CS
WVE icon

Credit Suisse’s Wave Life Sciences WVE Stock Holding History

Credit Suisse’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$794K Buy
128,720
+16,789
+15% +$84.1K ﹤0.01% 2399
2023
Q4 		$565K Buy
+111,931
New +$598K ﹤0.01% 2673
2022
Q3 		– Sell
-24
Closed – – 4336
2022
Q2 		$0 Buy
+24
New +$46 ﹤0.01% 4364
2021
Q2 		– Sell
-23,266
Closed -$130K – 4634
2021
Q1 		$130K Sell
23,266
-7,683
-25% -$73.8K ﹤0.01% 4172
2020
Q4 		$244K Buy
30,949
+9,246
+43% +$77.6K ﹤0.01% 4044
2020
Q3 		$184K Buy
21,703
+418
+2% +$4.58K ﹤0.01% 3850
2020
Q2 		$221K Buy
21,285
+11,013
+107% +$104K ﹤0.01% 3699
2020
Q1 		$96K Sell
10,272
-2,598
-20% -$22.1K ﹤0.01% 3832
2019
Q4 		$103K Sell
12,870
-1,287
-9% -$31.6K ﹤0.01% 4067
2019
Q3 		$291K Buy
14,157
+6,091
+76% +$140K ﹤0.01% 3713
2019
Q2 		$210K Sell
8,066
-3,072
-28% -$86.1K ﹤0.01% 3830
2019
Q1 		$432K Buy
11,138
+2,675
+32% +$109K ﹤0.01% 3417
2018
Q4 		$356K Buy
8,463
+1,651
+24% +$73.4K ﹤0.01% 3442
2018
Q3 		$341K Sell
6,812
-1,816
-21% -$81.9K ﹤0.01% 3469
2018
Q2 		$330K Sell
8,628
-376
-4% -$16.2K ﹤0.01% 3594
2018
Q1 		$361K Buy
9,004
+894
+11% +$37.6K ﹤0.01% 3511
2017
Q4 		$284K Sell
8,110
-3,410
-30% -$99.4K ﹤0.01% 3648
2017
Q3 		$251K Buy
+11,520
New +$231K ﹤0.01% 3827
2017
Q1 		– Sell
-8,738
Closed -$229K – 4102
2016
Q4 		$229K Buy
+8,738
New +$284K ﹤0.01% 3758

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Credit Suisse's WVE Position: Q1 2024 in Review

Credit Suisse increased its Wave Life Sciences (WVE) stake by 15% in Q1 2024, buying an estimated $84.1K and bringing the position to 128,720 shares worth $794K. The position accounts for ﹤0.01% of the portfolio, ranked #2399.

Credit Suisse first reported a position in WVE in Q4 2016 and has held it in 19 quarters since. 132 funds tracked by Wall St. Rank hold WVE as of Q1 2024.

  • Credit Suisse held 128,720 shares of Wave Life Sciences worth $794K as of Q1 2024.
  • Credit Suisse bought 16,789 Wave Life Sciences shares in Q1 2024, an estimated $84.1K.
  • Wave Life Sciences made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2399 holding.
  • Credit Suisse first reported a position in Wave Life Sciences in Q4 2016 and has held it in 19 quarters since.
  • 132 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.